Amisulpride

Amisulpride is an atypical antipsychotic of the benzamide class that selectively blocks dopamine D2 and D3 receptors. At low doses it acts as a presynaptic blocker improving negative symptoms; at higher doses it treats positive symptoms of schizophrenia. Mediocon Inc supplies pharmaceutical-grade Amisulpride meeting BP and EP standards.

Key Features

• Selective D2/D3 receptor antagonist
• BP/EP compliant quality
• Effective for both positive & negative symptoms
• Suitable for tablet formulations

Applications

• Schizophrenia tablets
• Dysthymia and negative symptom treatment
• Acute psychosis management
• Maintenance antipsychotic therapy

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings